iShares MSCI Singapore ETF vs Hims and Hers Health Inc — how do they compare? iShares MSCI Singapore ETF trades at $31.83, while Hims and Hers Health Inc trades at $34.79 (market cap $8.60B). The key difference: iShares MSCI Singapore ETF is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals.
| EWS | HIMS | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $32.09 | $66.18 |
52-Week Low | $26.47 | $14.52 |
Market Cap | — | $8.60B |
Enterprise Value | — | $8.98B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Hims & Hers Health trades at $35.52, up 1.05% today, with a bullish technical signal from moving averages and a consensus analyst price target of $33.57. Recent earnings show volatility with a Q1 2026 miss, but revenue grew to $2.35 billion in 2025. The company benefits from expansion in weight-loss therapies and a $400 million JPMorgan facility, though high valuations like a P/E of 57.14 and negative net income margin pose concerns.
Outlook is mixed: growth opportunities in telehealth and GLP-1 drugs support upside, but earnings inconsistency and regulatory risks from FDA reviews require caution. Analysts are 35% buy-rated, highlighting potential if execution improves, yet investors face volatility near key resistance at $38.
Trailing returns across standard periods
Latest headlines on both assets
EWS tracks the MSCI Singapore 25/50 Index, providing targeted exposure to large and mid-cap companies in Singapore. It is heavily weighted toward the financial, industrial, and real estate sectors, serving as a liquid tool for accessing Singapore's stable, dividend-oriented developed economy.
Read more on EWS →Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →